Returns At ASSEMS (KOSDAQ:136410) Appear To Be Weighed Down

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. However, after investigating ASSEMS (KOSDAQ:136410), we don't think it's current trends fit the mold of a multi-bagger.

Advertisement

What Is Return On Capital Employed (ROCE)?

For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. To calculate this metric for ASSEMS, this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.094 = ₩6.4b ÷ (₩102b - ₩34b) (Based on the trailing twelve months to March 2024).

Therefore, ASSEMS has an ROCE of 9.4%. On its own that's a low return, but compared to the average of 6.6% generated by the Chemicals industry, it's much better.

View our latest analysis for ASSEMS

roce
KOSDAQ:A136410 Return on Capital Employed August 6th 2024

Historical performance is a great place to start when researching a stock so above you can see the gauge for ASSEMS' ROCE against it's prior returns. If you're interested in investigating ASSEMS' past further, check out this free graph covering ASSEMS' past earnings, revenue and cash flow.

What Can We Tell From ASSEMS' ROCE Trend?

In terms of ASSEMS' historical ROCE trend, it doesn't exactly demand attention. The company has employed 75% more capital in the last five years, and the returns on that capital have remained stable at 9.4%. This poor ROCE doesn't inspire confidence right now, and with the increase in capital employed, it's evident that the business isn't deploying the funds into high return investments.

In Conclusion...

In conclusion, ASSEMS has been investing more capital into the business, but returns on that capital haven't increased. Since the stock has declined 28% over the last year, investors may not be too optimistic on this trend improving either. All in all, the inherent trends aren't typical of multi-baggers, so if that's what you're after, we think you might have more luck elsewhere.

If you want to continue researching ASSEMS, you might be interested to know about the 2 warning signs that our analysis has discovered.

While ASSEMS may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About KOSDAQ:A136410

Assems

Develops and sells adhesives in South Korea.

Flawless balance sheet with solid track record.

Advertisement

Weekly Picks

LO
Lou_Basenese
GANX logo
Lou_Basenese on Gain Therapeutics ·

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake

Fair Value:US$7.675.4% undervalued
10 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.2538.0% undervalued
14 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
TE
BUSER logo
TechMegaTrends on Bambuser ·

Bambuser is today the only listed company in Europe that simultaneously possesses an 85% gross margin, proprietary AI infrastructure for the

Fair Value:SEK 238.2690.3% undervalued
5 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
HE
HedgeY
CSTM logo
HedgeY on Constellium ·

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?

Fair Value:US$3410.6% undervalued
3 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

AS
AstrisCorporateAdvisory
9628 logo
AstrisCorporateAdvisory on SAN Holdings ·

Forging ahead with an ambitious growth plan

Fair Value:JP¥1.92k28.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
FA
VERDANT logo
FA_Trader on Verdant Solar Holdings Berhad ·

Verdant Solar: Continued share accumulation may be hinting that the worst is temporary, not structural

Fair Value:RM 0.4555.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DI
DinTang
P8Z logo
DinTang on Bumitama Agri ·

Expectations focused on stable output, disciplined costs, and continued cash returns to shareholders

Fair Value:S$2.4622.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3952.7% undervalued
45 users have followed this narrative
3 users have commented on this narrative
42 users have liked this narrative
RO
Robbo
TSLA logo
Robbo on Tesla ·

The academically fascinating Tesla

Fair Value:US$301.1k% overvalued
38 users have followed this narrative
11 users have commented on this narrative
32 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$587.3134.6% undervalued
1356 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative